ASX:SHLHealthcare
Should Sonic’s Resilient Dividend and European Expansion Amid Softer Testing Shape ASX:SHL’s Investment Case?
Sonic Healthcare has recently come under renewed scrutiny as its post‑pandemic testing revenues eased and profits softened, even while it continued to invest in international pathology, imaging and general practice operations across multiple regions.
An important feature of this period is the company’s decades-long record of maintaining or increasing dividends and its ongoing expansion through European acquisitions, which are reshaping its earnings mix and long‑term growth profile.
We’ll now...